Simvastatin in Critically Ill Patients with Covid-19.

REMAP-CAP Investigators, Paul Dark, et al.

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Simvastatin in Critically Ill Patients with Covid-19.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Agricultural and Biological Sciences